Kristen Lynn Mccaleb from San Francisco, CA, age 50

Resumes

Associate Director, Global Clinical Affairs

view source

Location:

San Francisco, CA

Industry:

Research

Work:

Exact Sciences
Associate Director, Global Clinical Affairs
Genomic Health
Associate Director Clinical Operations
Genomic Health
Operations Manager For Global Medical Affairs
Invitae Apr 2016 - May 2017
Program Manager For Medical Affairs
Ucsf Dec 2013 - Mar 2016
Program Manager - Genomic Medicine Initiative

Education:

University of Colorado 1996 - 2002
Doctorates, Doctor of Philosophy, Organic Chemistry University of Illinois at Urbana - Champaign 1992 - 1996
Bachelors, Bachelor of Science, Chemistry University of Colorado Boulder
Doctorates, Doctor of Philosophy

Skills:

Organic Chemistry
Drug Discovery
Chemistry
Life Sciences
Drug Development
Hplc
Biotechnology
Clinical Trials
Organic Synthesis
Research
Patents
Cro
Lc Ms
Drug Metabolism
Lifesciences
Molecular Biology
Nmr
Pharmaceutical Industry
High Performance Liquid Chromatography
Problem Solving

Consultant At San Francisco Otolaryngology Medical Group

view source

Position:

Consultant at San Francisco Otolaryngology Medical Group, Consultant at Research Specialists, LLC, Consultant at MobileMed Apps, LLC

Location:

San Francisco Bay Area

Industry:

Pharmaceuticals

Work:

San Francisco Otolaryngology Medical Group - San Francisco, CA since Feb 2011
Consultant
Research Specialists, LLC since Jul 2010
Consultant
MobileMed Apps, LLC - San Francisco, CA since Feb 2010
Consultant
American Chemical Society Feb 2010 - Mar 2010
Project Manager
Medicinal Chemistry, Roche Feb 2002 - Aug 2009
Research Scientist

Education:

University of Colorado 1996 - 2002
Ph.D, Organic Chemistry University of Illinois at Urbana-Champaign 1992 - 1996
B.S., Chemistry, with High Distinction

Skills:

Patents
Problem Solving
Drug Discovery
Organic Chemistry
Chemistry
Drug Metabolism

Honor & Awards:

2010 - ACS California & Santa Clara Valley Sections Outstanding Service Awards 2006 - ACS ChemLuminary Award Finalist National Chemistry Week Event - Teach the Teachers 2005 - Roche First 100 Volunteers Community Service Award 1999-2000 - Dow Agrosciences Graduate Fellowship 1999 - University of Colorado Graduate Travel Award 1996 - John S. Meek Teaching Award Outstanding Organic Chemistry Teaching Assistant 1995 - R. W. Johnson ACS Undergraduate Travel Award

Name / Title

Company / Classification

Phones & Addresses

Kristen Mccaleb
Managing

Research Specialists, LLC
Consulting

7083 Hollywood Blvd, Los Angeles, CA 90028
308 Oak Ct, Daly City, CA 94014

Us Patents

Substituted Pyrazolo[3,4-D]Pyrimidines As P38 Map Kinase Inhibitors
view source
US Patent:

7608603, Oct 27, 2009
Filed:

Aug 23, 2006
Appl. No.:

11/509121
Inventors:

Nolan James Dewdney - San Jose CA, US
Tobias Gabriel - San Francisco CA, US
Kristen Lynn McCaleb - Daly City CA, US
Assignee:

Roche Palo Alto LLC - Palo Alto CA
International Classification:

C07F 9/09
C07D 487/04
A61K 31/519
A61K 31/661
A61P 11/16
A61P 19/02
US Classification:

514 81, 5142621, 544244, 544262
Abstract:

Compounds of formula Ia, Ib, Ic, Id, Ie, If, Ig or Ih:.

Heterocyclic Antiviral Compounds
view source
US Patent:

8158631, Apr 17, 2012
Filed:

Jun 24, 2010
Appl. No.:

12/822630
Inventors:

Elbert Chin - San Jose CA, US
Javier de Vicente Fidalgo - Glen Ridge NJ, US
Jim Li - San Francisco CA, US
Alfred Sui-Ting Lui - Sunnyvale CA, US
Kristen Lynn McCaleb - Daly City CA, US
Ryan Craig Schoenfeld - San Jose CA, US
Francisco Xavier Talamas - Mountain View CA, US
Assignee:

Roche Palo Alto LLC - South San Francisco CA
International Classification:

A61K 31/497
C07D 241/02
US Classification:

5142521, 544224, 544242, 544336
Abstract:

Compounds having the formula I wherein R, R, R, R, and Rare as defined herein are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions and methods for treating an HCV infection and inhibiting HCV replication.

Dihydroquinone And Dihydronaphthridine Inhibitors Of Jnk
view source
US Patent:

8163906, Apr 24, 2012
Filed:

May 14, 2008
Appl. No.:

12/152432
Inventors:

Sarah C. Abbot - San Francisco CA, US
Geneviève N. Boice - Palo Alto CA, US
Bernd Buettelmann - Palo Alto CA, US
David Michael Goldstein - San Jose CA, US
Leyi Gong - San Mateo CA, US
Joan Heather Hogg - Sunnyvale CA, US
Pravin Iyer - Mountain View CA, US
Kristen Lynn McCaleb - Daly City CA, US
Assignee:

Roche Palo Alto, LLC - Palo Alto CA
International Classification:

C07D 471/04
US Classification:

544362, 546123
Abstract:

Compounds of formula I are effective modulators of JNK:.

Heterocyclic Antiviral Compounds
view source
US Patent:

8232271, Jul 31, 2012
Filed:

Oct 30, 2009
Appl. No.:

12/609160
Inventors:

Jim Li - San Francisco CA, US
Alfred Sui-Ting Lui - Sunnyvale CA, US
Kristen Lynn McCaleb - Daly City CA, US
Francisco Xavier Talamas - Mountain View CA, US
Assignee:

Roche Palo Alto LLC - South San Francisco CA
International Classification:

C07D 401/02
C07D 213/62
A61K 31/44
US Classification:

5142222, 5142278, 5142355, 51425313, 514318, 514335, 514336, 544 7, 544 59, 544131, 544360, 546193, 546255, 5462681, 546300
Abstract:

Compounds having the formula I wherein R, R, R, R, R, R, Rand p are as defined herein are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions and methods for treating an HCV infection and inhibiting HCV replication.

Pyrimidinyl Pyridone Inhibitors Of Jnk
view source
US Patent:

8404695, Mar 26, 2013
Filed:

Oct 22, 2009
Appl. No.:

12/603726
Inventors:

Genevieve N. Boice - Palo Alto CA, US
Leyi Gong - San Mateo CA, US
Kristen Lynn McCaleb - Daly City CA, US
Wylie Solang Palmer - Mountain View CA, US
Assignee:

Roche Palo Alto LLC - Palo Alto CA
International Classification:

C07D 471/04
A61K 31/519
A61P 35/00
A61P 19/00
A61P 29/00
A61P 37/08
A61P 3/10
A61P 25/28
A61P 25/16
A61P 35/02
US Classification:

51426411, 544279
Abstract:

This application discloses novel pyrimidinyl pyridone derivatives according to Formula I,.

Heteroaryl-Fused Pyrazolo Derivatives And Methods For Using The Same
view source
US Patent:

20050203091, Sep 15, 2005
Filed:

Feb 25, 2005
Appl. No.:

11/065890
Inventors:

Nidhi Arora - Cupertino CA, US
Roland Billedeau - Santa Clara CA, US
Nolan Dewdney - San Jose CA, US
Tobias Gabriel - San Francisco CA, US
David Goldstein - San Jose CA, US
Kristen McCaleb - Daly City CA, US
Michael Soth - Milpitas CA, US
Teresa Trejo-Martin - Union City CA, US
International Classification:

A61K031/5377
A61K031/519
C07D487/02
US Classification:

514234500, 544255000, 544114000, 514262100
Abstract:

Compounds of the formula I: where A, B, X, Y, Z, k, R, Rand Rare those defined herein, and compositions comprising the same. The present invention also provides methods for preparing compounds of formula I and using the same in treating p38 mediated disorders in a patient.

P38 Map Kinase Inhibitors And Methods For Using The Same
view source
US Patent:

20070054915, Mar 8, 2007
Filed:

Aug 23, 2006
Appl. No.:

11/509240
Inventors:

Nidhi Arora - Cupertino CA, US
Humberto Arzeno - Cupertino CA, US
Roland Billedeau - Santa Clara CA, US
Nolan Dewdney - San Jose CA, US
Kieran Durkin - Folsom CA, US
Tobias Gabriel - San Francisco CA, US
Kristen McCaleb - Daly City CA, US
Michael Soth - Milpitas CA, US
Dennis Yasuda - Campbell CA, US
International Classification:

A61K 31/519
A61K 31/498
C07D 487/02
US Classification:

514249000, 514262100, 544262000, 544350000
Abstract:

Compounds of formula or wherein A, W, X, Y, R, R, Rand Rare as defined herein. Also disclosed are methods of making the compounds and methods of using the compounds for treatment of pMAP kinase-mediated diseases.

Mobile Medical Information System And Methods Of Use
view source
US Patent:

20120101847, Apr 26, 2012
Filed:

Oct 19, 2011
Appl. No.:

13/277185
Inventors:

Jacob Johnson - San Francisco CA, US
Dianna Kane - San Francisco CA, US
Kristen McCaleb - Daly City CA, US
International Classification:

G06Q 50/24
G06Q 50/22
US Classification:

705 3, 705 2
Abstract:

Systems, methods and computer readable media performing mobile medical information management are provided. In one aspect, one or more web-based patient portals are accessed and medical history records of a patient are downloaded therefrom, based upon a user profile including personal information that uniquely identifies the patient. All or part of the downloaded data can be outputted to at least one of the patient and a physician or other authorized care provider treating or evaluating the patient.